Mindfulness meditation for people with ADHD? It may seem like a stretch, since difficulty with mindfulness is the very challenge for those with attention deficit hyperactivity disorder. And yet recent research shows that mindfulness training can be adapted for this condition and that it can improve concentration. Various clinicians and educators are already teaching mindfulness to people with ADHD as well as to overly stressed school children. Scientists have been trying for several decades to understand how attention works. Recent studies on mindfulness and attention have demonstrated that with a little work, participants can develop greater ability to focus and self-regulate. Lidia Zylowska, M.D, a psychiatrist and founding member of the Mindful Awareness Research Center (MARC), Susan Sm...MedWorm Message: Register for MedMatcha, MedWorm's medical advertising network, and receive $5 free advertising.

(Source: CNS Drugs)

(Source: CNS Drugs)

Conclusions: ADHD often presents as an impairing lifelong condition in adults, yet it is currently under diagnosed and treated in many European countries, leading to ineffective treatment and higher costs of illness. Expertise in diagnostic assessment and treatment of ADHD in adults must increase in psychiatry. Instruments for screening and diagnosis of ADHD in adults are available and appropriate treatments exist, although more research is needed in this age group. (Source: BMC Psychiatry - Latest articles)

Actavis has received approval from the U.S. Food & Drug Administration to market Atomoxetine HCl capsules for the treatment of attention deficit/hyperactivity disorder (ADHD). (Source: Disabled World)

Actavis has received approval from the U.S. Food & Drug Administration to market Atomoxetine HCl capsules for the treatment of attention deficit/hyperactivity disorder (ADHD). (Source: Pharmaceutical Online News)MedWorm Message: Register for MedMatcha, MedWorm's medical advertising network, and receive $5 free advertising.

Actavis has received approval from the U.S. Food & Drug Administration to market Atomoxetine HCl capsules for the treatment of attention deficit/hyperactivity disorder (ADHD). Actavis intends to market Atomoxetine HCl in 10 mg, 18 mg, 25 mg, 40 mg, 60 mg, 80 mg and 100 mg strengths. No release date for Atomoxetine, Actavis' generic equivalent to Eli Lilly and Company's Strattera®, has been set. The U.S. Court of Appeals for the Federal Circuit is reviewing an Aug. 12 ruling that invalidated Lilly's patent, which is due to expire in 2017. U.S... (Source: Health News from Medical News Today)

Abstract (Source: Acta Paediatrica)

Abstract (Source: Acta Paediatrica)

Sun Pharmaceutical Industries Ltd. (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE:SUNPHARMA, BSE: 524715) announced that USFDA has granted its subsidiary an approval for its Abbreviated New Drug Application (ANDA) to market a generic version of Strattera ®, atomoxetine hydrochloride capsules. These generic atomoxetine hydrochloride capsules are equivalent to Eli Lilly's Strattera ® capsules and include six strengths: 10 mg, 18 mg, 25 mg, 40 mg, 60 mg, and 100 mg... (Source: Health News from Medical News Today)

(Source: AAP Grand Rounds)MedWorm Message: Register for MedMatcha, MedWorm's medical advertising network, and receive $5 free advertising.

CONCLUSIONS: Analyses provide additional evidence that the total Empowerment Scale score is a reliable, valid measure; subscales of the scale appear less robust. Empowerment is considered an essential factor in recovery-oriented programs and systems, and the use of psychometrically sound measures such as the Empowerment Scale therefore may be useful to evaluators. (Source: Psychiatr Serv)

It has received approval to sell generic strattera capsules, used in treating attention deficit hyperactivity disorder, in the American market (Source: The Economic Times Healthcare and Biotech News)

It has received approval to sell generic strattera capsules, used in treating attention deficit hyperactivity disorder, in the American market (Source: The Economic Times Healthcare and Biotech News)

It has received approval to sell generic strattera capsules, used in treating attention deficit hyperactivity disorder, in the American market (Source: The Economic Times Healthcare and Biotech News)

It has received approval to sell generic strattera capsules, used in treating attention deficit hyperactivity disorder, in the American market (Source: The Economic Times Healthcare and Biotech News)

It has received approval to sell generic strattera capsules, used in treating attention deficit hyperactivity disorder, in the American market (Source: The Economic Times Healthcare and Biotech News)

Conclusion: The results support the notion that the SHR strain is a useful animal model system to investigate potential molecular mechanisms underlying fine motor skill problems in children with ADHD. (Source: Behavioral and Brain Functions)

Developmental dyslexia (reading disability) is a specific impairment in learning to read that affects 3–6% of school children in English-speaking countries. It is overrepresented in clinical populations referred to child and adolescent mental health services because of its high comorbidity with conduct disorder, attention-deficit hyperactivity disorder and other developmental disorders. Clinicians may fail to identify it unless they maintain a high degree of awareness and make specific inquiries. A three-stage approach (routine screening, in-depth examination and referral for further testing) is described. The features of dyslexia and the clues to its diagnosis are discussed. A number of simple tests for identifying it are available and familiarity with these should improve diagnosti...MedWorm Message: Register for MedMatcha, MedWorm's medical advertising network, and receive $5 free advertising.

Journal of Child and Adolescent Psychopharmacology Aug 2010, Vol. 20, No. 4: 283-289. (Source: Journal of Child and Adolescent Psychopharmacology)